Article
Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients.
International journal of molecular sciences - 29 Jan 2020
Zhu Jing, Patel Tejendra, Miller Jordan A, Torrice Chad D, Aggarwal Mehak, Sketch Margaret R, Alexander Maurice D, Armistead Paul M, Coghill James M, Grgic Tatjana, Jamieson Katarzyna J, Ptachcinski Jonathan R, Riches Marcie L, Serody Jonathan S, Schmitz John L, Shaw J Ryan, Shea Thomas C, Suzuki Oscar, Vincent Benjamin G, Wood William A, Rao Kamakshi V, Wiltshire Tim, Weimer Eric T, Crona Daniel J
Abstract excerpt
Tacrolimus exhibits high inter-patient pharmacokinetics (PK) variability, as well as a narrow therapeutic index, and therefore requires therapeutic drug monitoring. Germline mutations in cytochrome P450 isoforms 4 and 5 genes (CYP3A4/5) and the ATP-binding cassette B1 gene (ABCB1) may contribute to interindividual tacrolimus PK variability, which may impact clinical outcomes among allogeneic hematopoietic stem...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
